
American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …

Johnson & Johnson and research arm Janssen have taken the decision to terminate a Phase 3 trial evaluating the efficacy …

The first patient has been treated in the Phase III clinical trial, which sees Merck (ETR: MRK) and Pfizer (NYSE: …
Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …

